Drugs and nanoformulations for the management of Leishmania infection: a patent and literature review (2015-2022)
Sign Up to like & getrecommendations! Published in 2023 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2023.2201431
Abstract: ABSTRACT Introduction Leishmaniasis is an important disease caused by parasites of the Leishmania. Due to the urgent need for financial incentives and research and development of new anti-Leishmania, a point that stands out is the… read more here.
Keywords: drugs nanoformulations; 2015 2022; leishmania infection; treatment ... See more keywords